Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report

BACKGROUND: Immune checkpoint inhibitors are new immunotherapy drugs globally used for many malignancies, including renal cell carcinoma. Myocarditis as an immune-related adverse event is rare but highly fatal, suggesting that its frequency may be higher than reported. This paper describes a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Yasuyuki, Naito, Hirohito, Tsunemori, Hiroyuki, Tani, Ryosuke, Hasui, Yusuke, Miyake, Yuichi, Minamino, Tetsuo, Ishikawa, Ryo, Kushida, Yoshio, Haba, Reiji, Sugimoto, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518217/
https://www.ncbi.nlm.nih.gov/pubmed/34649593
http://dx.doi.org/10.1186/s13256-021-03097-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518217/
https://www.ncbi.nlm.nih.gov/pubmed/34649593
http://dx.doi.org/10.1186/s13256-021-03097-6

Ejemplares similares